RFK Jr.'s hand-picked committee approves manufacture of peptides he uses
Despite the absence of human safety or efficacy data, the importance of such information appears to be diminishing in decision-making processes.
MAIN POINTS
- Human safety data is currently unavailable for certain situations.
- Efficacy data for humans is also lacking.
- The absence of this data does not seem to impact decisions.
- The significance of safety and efficacy data is being questioned.
TAKEAWAYS
- Decision-making may proceed without comprehensive safety data.
- Efficacy information is not always a prerequisite for action.
- The role of data in ensuring safety is under scrutiny.
- The trend reflects a shift in data-driven decision priorities.